Log in to save to my catalogue

Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognost...

Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognost...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_507659b064f9467ea027987656c38642

Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period

About this item

Full title

Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period

Publisher

Milan: Springer Milan

Journal title

Journal of headache and pain, 2021-12, Vol.22 (1), p.60-60, Article 60

Language

English

Formats

Publication information

Publisher

Milan: Springer Milan

More information

Scope and Contents

Contents

Background
Altered glutamatergic neurotransmission and neuropeptide levels play a central role in migraine pathomechanism. Previously, we confirmed that kynurenic acid, an endogenous glutamatergic antagonist, was able to decrease the expression of pituitary adenylate cyclase-activating polypeptide 1–38, a neuropeptide with known migraine-inducin...

Alternative Titles

Full title

Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_507659b064f9467ea027987656c38642

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_507659b064f9467ea027987656c38642

Other Identifiers

ISSN

1129-2369

E-ISSN

1129-2377

DOI

10.1186/s10194-021-01239-1

How to access this item